tetano
Editor, Senior Moderator
BMJ Case Rep. 2020 May 13;13(5). pii: e236080. doi: 10.1136/bcr-2020-236080.
Hypogeusia as the initial presenting symptom of COVID-19.
Melley LE[SUP]1[/SUP], Bress E[SUP]2[/SUP], Polan E[SUP]3[/SUP].
Author information
Abstract
COVID-19 is the disease caused by the novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which first arose in Wuhan, China, in December 2019 and has since been declared a pandemic. The clinical sequelae vary from mild, self-limiting upper respiratory infection symptoms to severe respiratory distress, acute cardiopulmonary arrest and death. Otolaryngologists around the globe have reported a significant number of mild or otherwise asymptomatic patients with COVID-19 presenting with olfactory dysfunction. We present a case of COVID-19 resulting in intensive care unit (ICU) admission, presenting with the initial symptom of disrupted taste and flavour perception prior to respiratory involvement. After 4 days in the ICU and 6 days on the general medicine floor, our patient regained a majority of her sense of smell and was discharged with only lingering dysgeusia. In this paper, we review existing literature and the clinical course of SARS-CoV-2 in relation to the reported symptoms of hyposmia, hypogeusia and dysgeusia.
? BMJ Publishing Group Limited 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
KEYWORDS:
adult intensive care; ear, nose and throat/otolaryngology; infectious diseases; mouth; pneumonia (respiratory medicine)
PMID:32404376DOI:10.1136/bcr-2020-236080
Hypogeusia as the initial presenting symptom of COVID-19.
Melley LE[SUP]1[/SUP], Bress E[SUP]2[/SUP], Polan E[SUP]3[/SUP].
Author information
Abstract
COVID-19 is the disease caused by the novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which first arose in Wuhan, China, in December 2019 and has since been declared a pandemic. The clinical sequelae vary from mild, self-limiting upper respiratory infection symptoms to severe respiratory distress, acute cardiopulmonary arrest and death. Otolaryngologists around the globe have reported a significant number of mild or otherwise asymptomatic patients with COVID-19 presenting with olfactory dysfunction. We present a case of COVID-19 resulting in intensive care unit (ICU) admission, presenting with the initial symptom of disrupted taste and flavour perception prior to respiratory involvement. After 4 days in the ICU and 6 days on the general medicine floor, our patient regained a majority of her sense of smell and was discharged with only lingering dysgeusia. In this paper, we review existing literature and the clinical course of SARS-CoV-2 in relation to the reported symptoms of hyposmia, hypogeusia and dysgeusia.
? BMJ Publishing Group Limited 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
KEYWORDS:
adult intensive care; ear, nose and throat/otolaryngology; infectious diseases; mouth; pneumonia (respiratory medicine)
PMID:32404376DOI:10.1136/bcr-2020-236080